Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.230
+0.120 (10.81%)
At close: Mar 6, 2026, 4:00 PM EST
1.210
-0.020 (-1.63%)
After-hours: Mar 6, 2026, 7:59 PM EST
Immunic Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 21.25 | 18.01 | 16.01 | 15.26 | 13.3 | |
| Research & Development | 81.98 | 80.05 | 83.22 | 71.26 | 61.12 | |
| Operating Expenses | 103.23 | 98.05 | 99.22 | 86.52 | 74.42 | |
| Operating Income | -103.23 | -98.05 | -99.22 | -86.52 | -74.42 | |
| Interest & Investment Income | 1.04 | 3.39 | 3.08 | 1.04 | 0.07 | |
| Other Non Operating Income (Expenses) | 6.72 | -1.05 | 2.54 | -1.96 | -1.35 | |
| EBT Excluding Unusual Items | -95.47 | -95.71 | -93.61 | -87.44 | -75.7 | |
| Impairment of Goodwill | - | - | - | -32.97 | - | |
| Asset Writedown | - | -4.8 | - | - | - | |
| Other Unusual Items | -1.7 | - | - | - | -17.25 | |
| Pretax Income | -97.17 | -100.51 | -93.61 | -120.41 | -92.95 | |
| Net Income | -97.17 | -100.51 | -93.61 | -120.41 | -92.95 | |
| Net Income to Common | -97.17 | -100.51 | -93.61 | -120.41 | -92.95 | |
| Shares Outstanding (Basic) | 156 | 100 | 44 | 32 | 24 | |
| Shares Outstanding (Diluted) | 156 | 100 | 44 | 32 | 24 | |
| Shares Change (YoY) | 55.42% | 126.03% | 39.29% | 34.52% | 51.00% | |
| EPS (Basic) | -0.62 | -1.00 | -2.11 | -3.78 | -3.93 | |
| EPS (Diluted) | -0.62 | -1.00 | -2.11 | -3.78 | -3.93 | |
| Free Cash Flow | -85.97 | -85.03 | -71.16 | -65.26 | -83.3 | |
| Free Cash Flow Per Share | -0.55 | -0.85 | -1.61 | -2.05 | -3.52 | |
| EBITDA | -103.06 | -97.92 | -99.11 | -86.44 | -74.33 | |
| D&A For EBITDA | 0.17 | 0.13 | 0.11 | 0.08 | 0.09 | |
| EBIT | -103.23 | -98.05 | -99.22 | -86.52 | -74.42 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.